Article Text

Download PDFPDF
Abnormal fundus autofluorescence patterns in myopic choroidal neovascularisation
  1. M Sawa,
  2. F Gomi,
  3. M Tsujikawa,
  4. Y Ikuno,
  5. H Sakaguchi,
  6. K Sayanagi,
  7. Y Tano
  1. Department of Ophthalmology, Osaka University Medical School, Japan
  1. Dr M Sawa, Department of Ophthalmology, Osaka University Medical School, Japan, Room E7, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan; sawamiki{at}ophthal.med.osaka-u.ac.jp

Abstract

Background/aims: To investigate fundus autofluorescence (FAF) findings in eyes with myopic choroidal neovascularisation (CNV).

Methods: Observational case series. Twenty-seven consecutive eyes with CNV for at least 1 year were included. FAF patterns, time after the onset of CNV seen on FAF and FAF changes were evaluated.

Results: The following patterns were observed: pattern I (n = 2), relative hypoautofluorescence around the CNV surrounded by hyperautofluorescence a mean of 17 months after CNV onset; pattern II (n = 11), small lobular or multilobular well-defined FAF defects within a relatively hypoautofluorescent region surrounded by hyperautofluorescence a mean of 35 months after onset; pattern III (n = 4), large lobular or multilobular well-defined FAF defects surrounded by hyperautofluorescence a mean of 59 months after onset; and pattern IV (n = 10), large lobular or crescent-shaped well-defined FAF defects a mean of 107 months after onset. Well-defined FAF defects corresponded to chorioretinal atrophy on colour fundus photographs. During the follow-up period, two eyes with pattern I evolved into pattern II. Lobular or multilobular well-defined FAF defects enlarged in 11 eyes (pattern II, nine eyes; pattern III, two eyes).

Conclusion: Autofluorescent changes progress over time through pattern grading. A pattern classification might be helpful to predict chorioretinal atrophy changes around myopic CNV.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Funding: Supported by a research grant 18791276 from the Japan Society for the Promotion of Science, Tokyo, Japan.

  • Competing interests: None.

  • Ethics approval: Ethics approval was obtained from the institutional review board of Osaka University Medical School Hospital.

  • Patient consent: Obtained.